Delivery Order SPE2D021DA002-SPE2D326F0199
- Not listed
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector units (quantity 2). This firm fixed-price delivery order, valued at $1,742.50, was issued on October 2, 2025, with an ultimate completion date of October 3, 2025, and does not include a set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for epinephrine 0.3 mg auto-injector kits (two-pack) with a contract ceiling value of $1,045.50. The award, issued on June 27, 2025, with an ultimate completion date of July 2, 2025, was made without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge,...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain function, awarded a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-inject 2-packs. The delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, is structured as a firm fixed-price contract with no set-aside designation. The product will be delivered to Park Ridge, Illinois, the location of the prime contractor's...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award, issued on September 5, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,983.53 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and performance to be fulfilled in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,395.15 to DMS Pharmaceutical Group Inc. on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at DMS Pharmaceutical Group's facility in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 29, 2025, for epinephrine 0.3 mg auto-injector supplies (2-pack) valued at $1,219.75. This firm fixed-price delivery order, issued without set-aside designation, supports the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 30, 2025. The award is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F0199Delivery Order
The Defense Logistics Agency (DLA), acting under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 2, 2025, has a ceiling value of $1,916.75 and is scheduled for completion by October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance by the vendor from its location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is executing this delivery order under its larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and extending through November 2026. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. This epinephrine auto-injector delivery supports the military health system's medical supply requirements and reflects DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/2/25 |